167 related articles for article (PubMed ID: 2258908)
1. Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3222-9. PubMed ID: 2258908
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3216-22. PubMed ID: 2258907
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
[TBL] [Abstract][Full Text] [Related]
4. Resolution, molecular structure and biological activities of the D- and L-enantiomers of potent anti-implantation agent, DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran.
Hajela K; Pandey J; Dwivedy A; Dhar JD; Sarkhel S; Maulik PR; Velumurugan D
Bioorg Med Chem; 1999 Sep; 7(9):2083-90. PubMed ID: 10530958
[TBL] [Abstract][Full Text] [Related]
5. Structure activity relationship of some 2,3-diaryl-2H-1-benzopyrans to their anti-implantation, estrogenic and antiestrogenic activities in rat.
Dhar JD; Dwivedi A; Srivastava A; Setty BS
Contraception; 1994 Jun; 49(6):609-16. PubMed ID: 8070266
[TBL] [Abstract][Full Text] [Related]
6. (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
Gauthier S; Caron B; Cloutier J; Dory YL; Favre A; Larouche D; Mailhot J; Ouellet C; Schwerdtfeger A; Leblanc G; Martel C; Simard J; Mérand Y; Bélanger A; Labrie C; Labrie F
J Med Chem; 1997 Jul; 40(14):2117-22. PubMed ID: 9216828
[No Abstract] [Full Text] [Related]
7. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.
Martel C; Provencher L; Li X; St Pierre A; Leblanc G; Gauthier S; Mérand Y; Labrie F
J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):199-205. PubMed ID: 9605415
[TBL] [Abstract][Full Text] [Related]
9. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
10. Antifertility potential of 2-[piperdinoethoxyphenyl]-3-[4- methoxyphenyl]-2H benzopyran: a potent anti-oestrogenic compound in rats.
Singh R
J Reprod Fertil; 1996 Jan; 106(1):49-53. PubMed ID: 8667345
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
[TBL] [Abstract][Full Text] [Related]
12. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
13. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies.
Dickerson R; Keller LH; Safe S
Toxicol Appl Pharmacol; 1995 Dec; 135(2):287-98. PubMed ID: 8545839
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of tissue selectivity in estrogen receptor modulators.
Grese TA; Sluka JP; Bryant HU; Cullinan GJ; Glasebrook AL; Jones CD; Matsumoto K; Palkowitz AD; Sato M; Termine JD; Winter MA; Yang NN; Dodge JA
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14105-10. PubMed ID: 9391160
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
16. Pure antiestrogens and breast cancer.
Elkak AE; Mokbel K
Curr Med Res Opin; 2001; 17(4):282-9. PubMed ID: 11922402
[TBL] [Abstract][Full Text] [Related]
17. CDRI-85/287, a novel antiestrogen and antiimplantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus.
Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
Contraception; 1992 Jan; 45(1):81-92. PubMed ID: 1591925
[TBL] [Abstract][Full Text] [Related]
18. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
[TBL] [Abstract][Full Text] [Related]
19. Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Nov; 30(11):968-71. PubMed ID: 1293041
[TBL] [Abstract][Full Text] [Related]
20. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
